Inflammatory mediator profile in urine and bladder wash fluid of patients with interstitial cystitis.
Interstitial cystitis is a syndrome of urinary urgency, frequency and suprapubic pain. We investigated the role of inflammatory mediators in 96 patients with histories and symptoms consistent with interstitial cystitis, and 13 controls from The New York Hospital-Cornell Medical Center, University of Washington and University of California at San Diego. Patients were classified into either group A (meets all criteria of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases for inclusion in research studies), group B (meets all of these criteria but without glomerulations) or an "other" group. A small number of group A patients had detectable interleukin-6 in the urine. Urinary concentrations of tumor necrosis factor, prostaglandins E2, D2 and F2 alpha, and thromboxane B2 were not different among either patient groups or controls. Urine specimens contained inhibitors of the bioactivity of interleukin-6 and tumor necrosis factors but no differences between patients or controls were found. No factors chemotactic for human neutrophils were detected in a small patient sample. Bladder wash fluid concentrations of prostaglandins E2, D2 and F2 alpha, and thromboxane were much lower than urinary levels. Bladder wash fluid interleukin-6 and tumor necrosis factor were not detectable. The results suggest that while a small subset of patients may have elevated levels of interleukin-6 the majority of patients do not appear to have elevated levels of inflammatory mediators in the urine or bladder wash fluid. Evaluation of patient bladder tissue may indicate changes not detectable in urine or bladder wash fluid. Alternatively, other etiologies must be considered in those patients.
Felsen
D
D
Department of Urology, New York Hospital-Cornell Medical Center, New York 10021.
Frye
S
S
Trimble
L A
LA
Bavendam
T G
TG
Parsons
C L
CL
Sim
Y
Y
Vaughan
E D
ED
D000328:Adult; D002630:Chemotactic Factors / Q000032:analysis / Q000652:urine*; D003556:Cystitis / Q000276:immunology* / Q000473:pathology / Q000503:physiopathology / Q000652:urine*; D015777:Eicosanoids / Q000032:analysis / Q000652:urine*; D005260:Female; D006801:Humans; D015850:Interleukin-6 / Q000032:analysis / Q000652:urine*; D008297:Male; D007507:Therapeutic Irrigation; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis / Q000037:antagonists & inhibitors / Q000652:urine*; D001743:Urinary Bladder / Q000503:physiopathology; D000093242:Interleukin-6 Inhibitors
D002630:Chemotactic Factors; D015777:Eicosanoids; D015850:Interleukin-6; D014409:Tumor Necrosis Factor-alpha; D000093242:Interleukin-6 Inhibitors